How the interaction occurs:
The cause of this interaction is not known.
What might happen:
If you take pegvisomant and the somatostatin analogue octreotide together, you may be at risk of having increased liver enzymes resulting in potential damage to your liver.
What you should do about this interaction:
Make sure your healthcare professionals (e.g. doctor or pharmacist) know that you are taking these medicines together.Your healthcare professionals may already be aware of this interaction and may be monitoring you for it. Do not start, stop, or change the dosage of any medicine before checking with them first.Reference:1.Somavert (pegvisomant) Canadian prescribing information. Pfizer October, 2005.